首页> 外文OA文献 >Optimized dosage and frequency of cefozopran for patients with febrile neutropenia based on population pharmacokinetic and pharmacodynamic analysis

【2h】

Optimized dosage and frequency of cefozopran for patients with febrile neutropenia based on population pharmacokinetic and pharmacodynamic analysis

机译：基于人口药代动力学和药物动力学分析的红细胞患者优化的剂量和频率

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
K. Nomura; N. Morikawa; K. Ikawa; K. Ikeda; Y. Fujimoto; D. Shimizu; K. Taniguchi; K. Shimura; Y. Kanbayashi; T. Komori; Y. Matsumoto; N. Fujita; C. Shimazaki; M. Taniwaki;
展开▼
作者单位

展开▼
年度 2008
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Optimized dosage and frequency of cefozopran for patients with febrile neutropenia based on population pharmacokinetic and pharmacodynamic analysis [J] . Kenichi Nomura12 Norifumi Morikawa3 Kazuro Ikawa3 Kayo Ikeda3 Yoshiko Fujimoto1 Daisuke Shimizu1 Kyoko Taniguchi1 Kazuho Shimura1 Yuko Kanbayashi4 Toshiaki Komori5 Yosuke Matsumoto1 Naohisa Fujita5 Chihiro Shimazaki1 and Masafumi Taniwaki15 Journal of Antimicrobial Chemotherapy . 2008,第4期

机译：基于群体药代动力学和药效学分析的高热中性粒细胞减少症患者最佳剂量和频率
2. Optimized dosage and frequency of cefozopran for patients with febrile neutropenia based on population pharmacokinetic and pharmacodynamic analysis. [J] . Nomura K, Morikawa N, Ikawa K, The Journal of Antimicrobial Chemotherapy . 2008,第4期

机译：根据人群药代动力学和药效学分析，优化高热中性粒细胞减少症患者的头孢唑普兰剂量和频率。
3. Optimal treatment schedule of meropenem for adult patients with febrile neutropenia based on pharmacokinetic-pharmacodynamic analysis [J] . OhataY., TomitaY., NakayamaM., Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy . 2011,第6期

机译：基于药代动力学-药效学分析的美洛培南成年发热性中性粒细胞减少症患者最佳治疗方案
4. A Set-Based Optimal Control Approach for Pharmacokinetic/Pharmacodynamic Drug Dosage Design [C] . Sergio Lucia, Monica Schliemann-Bullinger, Rolf Findeisen, IFAC Symposium on Dynamics and Control of Process Systems Including Biosystems . 2016

机译：一种基于组的药代动力学/药效药物剂量设计的最优控制方法
5. Beta-lactam antimicrobial dosing optimization in obese patients compared to non-obese patients using population pharmacokinetic/pharmacodynamic approach. [D] . Chung, Eun Kyoung. 2015

机译：使用群体药代动力学/药效学方法，与非肥胖患者相比，肥胖患者的β-内酰胺抗菌药物剂量优化。
6. Population Pharmacokinetics and Pharmacodynamics Modeling To Optimize Dosage Regimens of Sulbactam in Critically Ill Patients with Severe Sepsis Caused by Acinetobacter baumannii [O] . Sutep Jaruratanasirikul, Wibul Wongpoowarak, Thitima Wattanavijitkul, 2016

机译：人群药代动力学和药效学模型可优化鲍曼不动杆菌引起的重症脓毒症重症患者的舒巴坦剂量方案
7. Clinical Trial Simulations for Dosage Optimization of Docetaxel in Patients with Liver Dysfunction, Based on a Log-binominal Regression for Febrile Neutropenia [O] . Kazuhiro OZAWA, Hironobu MINAMI, Hitoshi SATO 2009

机译：肝功能障碍患者Docetaxel剂量优化的临床试验模拟，基于Febrile Neuropenia的Log-Xinominal回归

Optimized dosage and frequency of cefozopran for patients with febrile neutropenia based on population pharmacokinetic and pharmacodynamic analysis

著录项

引文网络

相似文献

相关主题

期刊订阅